Medpace CEO August J. Troendle sells 10,880 shares for $6.75 million

Medpace Holdings President and CEO August J. Troendle sold 10,880 common shares on Sept. 17, 2026, for $620.4 per share, totaling $6.75 million. Following the sale, Troendle's directly held stake decreased to 504,273 shares, while he retained indirect holdings of 4.73 million shares through Medpace Investors.